PharmaResources adheres to the Quality by Design (QbD) philosophy toprovide customers one-stop efficient solutions through synthetic route design and screening, process optimization, scale-up, validation and process safety assessment, and thus improve customers’ R&D efficiency and shorten the drug development cycle. The innovative drug process development services provided by the company cover the entire process from preclinical studies to new drug launch.
Our new drug process development services have broken through known synthetic pathways or pioneering innovative synthetic process routes to achieve customized optimization from preclinical to new drug market launch.
We conduct research and define key process parameters to support scale-up, process validation, and commercial manufacturing .for cGMP or non-cGMP manufacturing
PharmaResources is committed to discovering and developing innovative synthetic processes, by establishment of platforms such as flow chemistry, enzymatic catalysis, asymmetric catalysis, solid-state chemistry and safety assessment. These platforms support process R&D and optimization, quality research, and help clients achieve low-cost, safe, green, and reliable commercial manufacturing of intermediates and APIs from kilograms to tons.